Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ferrera

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Scientific Reports|July 26, 2017
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant responseEmiliano Manzo, Adele Cutignano, Dario Pagano, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancerDaniela Fenoglio, Paolo Traverso, Alessia Parodi, et al.
Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.
Clinical and Experimental Medicine|November 14, 2022
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunctionChiara Dentone, Daniela Fenoglio, Alessia Parodi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
Cancers|June 2, 2021
Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck CancerDaniela Fenoglio, Liliana Belgioia, Alessia Parodi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Scientific Reports|July 26, 2017
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant responseEmiliano Manzo, Adele Cutignano, Dario Pagano, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancerDaniela Fenoglio, Paolo Traverso, Alessia Parodi, et al.
Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.
Clinical and Experimental Medicine|November 14, 2022
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunctionChiara Dentone, Daniela Fenoglio, Alessia Parodi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
Cancers|June 2, 2021
Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck CancerDaniela Fenoglio, Liliana Belgioia, Alessia Parodi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.
Pageof 3